摘要:
The present invention provides the compound having formula (I), wherein each of R1 and R2 is, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, -O-, -S-, -NH-, or -CH2-; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.
摘要:
2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide compounds are disclosed as useful in the treatment of obesity and related conditions. Processes for their preparation are described, as are novel intermediates and pharmaceutical compositions containing them.
R 1 Alkyl mit 1 bis 4 C-Atomen, Alkenyl oder Alkinyl mit 3 oder 4 C-Atomen, Haloalkenyl mit 3 oder 4 C-Atomen und 1 bis 3 Halogensubstituenten, ggf. halo- und/oder alkylsubstituiertes Thienyl, R 2 Alkyl mit 1 bis 4 C-Atomen R 3 Formyl, einen Rest der allgemeinen Formel R 4 XCHXR 5 , wobei X = 0 oder S und R 4 , R 5 gleiches oder verschiedenes Alkyl oder gemeinsam Alkylen mit jeweils 1 bis 4 C - Atomen bedeutet und der zusätzlich durch Alkyl, Alkoxy, Alkylthio, Hydroxy, Halogen, Cyano, N,N-Dialkylamino substituiert sein kann. bedeuten, eine gute herbizide Wirkung vorzugsweise gegen Arten aus der Familie der Gräser haben.
摘要:
The present invention relates to methods for the identification of HD AC interacting compounds using the ligand having the structure wherein R is H, C1-C6 alkyl, or cycloalkyl and X is a C1-C6 alkyl, cycloalkyl or an aryl, wherein the ligand is immobilized on a solid support via the NHR-group as well as to compounds having said structures.